Simplex Trading’s Vaxcyte PCVX Stock Holding History

Simplex Trading’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.57K	Buy	+133	New	+$7.75K	﹤0.01%	7825
2026 Q1	–	Sell	-1,549	Closed	-$84.1K	–	9876
2025 Q4	$71.5K	Buy	+1,549	New	+$69.3K	﹤0.01%	5319
2025 Q1	–	Sell	-12,818	Closed	-$1.02M	–	9368
2024 Q4	$1.05M	Buy	12,818 +12,485	+3,749%	+$1.24M	﹤0.01%	2792
2024 Q3	$38K	Buy	+333	New	+$30K	﹤0.01%	6141
2023 Q1	–	Sell	-9,776	Closed	-$415K	–	9848
2022 Q4	$468K	Sell	9,776 -197	-2%	-$7.73K	﹤0.01%	3219
2022 Q3	$239K	Buy	9,973 +9,667	+3,159%	+$245K	﹤0.01%	4388
2022 Q2	$6K	Buy	+306	New	+$7.08K	﹤0.01%	8738

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Simplex Trading's PCVX Position: Q3 2026 in Review

Simplex Trading opened a new position in Vaxcyte (PCVX) in Q3 2026: 133 shares worth $7.57K. The stake represents ﹤0.01% of the portfolio and ranks #7825 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCVX as recently as Q4 2025.

Simplex Trading first reported a position in PCVX in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2024. 167 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

Simplex Trading held 133 shares of Vaxcyte worth $7.57K as of Q3 2026.
Vaxcyte was a new Simplex Trading position in Q3 2026.
Vaxcyte made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7825 holding.
Simplex Trading first reported a position in Vaxcyte in Q2 2022 and has held it in 7 quarters since.
Simplex Trading's Vaxcyte position peaked at $1.05M in Q4 2024.
167 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.